Back to Search
Start Over
Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
- Source :
-
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2019 Jun 01; Vol. 17 (6), pp. 721-749. - Publication Year :
- 2019
-
Abstract
- Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. Recent advances have resulted in an expansion of treatment options for AML, especially concerning targeted therapies and low-intensity regimens. This portion of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AML focuses on the management of AML and provides recommendations on the workup, diagnostic evaluation and treatment options for younger (age <60 years) and older (age ≥60 years) adult patients.
- Subjects :
- Age Factors
Aged
Antineoplastic Combined Chemotherapy Protocols standards
Biomarkers, Tumor genetics
Biomarkers, Tumor immunology
Cytogenetic Analysis standards
Disease-Free Survival
Graft vs Host Disease immunology
Graft vs Host Disease prevention & control
HLA Antigens immunology
Hematopoietic Stem Cell Transplantation adverse effects
Histocompatibility Testing standards
Humans
Leukemia, Myeloid, Acute diagnosis
Leukemia, Myeloid, Acute mortality
Middle Aged
Remission Induction methods
Risk Assessment standards
Transplantation, Homologous adverse effects
United States
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Biomarkers, Tumor analysis
Hematopoietic Stem Cell Transplantation standards
Leukemia, Myeloid, Acute therapy
Medical Oncology standards
Subjects
Details
- Language :
- English
- ISSN :
- 1540-1413
- Volume :
- 17
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Journal of the National Comprehensive Cancer Network : JNCCN
- Publication Type :
- Academic Journal
- Accession number :
- 31200351
- Full Text :
- https://doi.org/10.6004/jnccn.2019.0028